These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35061691)

  • 41. Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro.
    Csernus V; Schally AV; Groot K
    Peptides; 1999; 20(7):843-50. PubMed ID: 10477085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults.
    Grossman A; Savage MO; Lytras N; Preece MA; Sueiras-Diaz J; Coy DH; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):321-30. PubMed ID: 6236914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and Functional Characterization of ssDNA Aptamers that Specifically Bind Leishmania infantum PABP.
    Guerra-Pérez N; Ramos E; García-Hernández M; Pinto C; Soto M; Martín ME; González VM
    PLoS One; 2015; 10(10):e0140048. PubMed ID: 26457419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.
    Rekasi Z; Czompoly T; Schally AV; Boldizsar F; Varga JL; Zarandi M; Berki T; Horvath RA; Nemeth P
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3435-40. PubMed ID: 15728367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New analogs of human growth hormone-releasing hormone (1-29) with high and prolonged antagonistic activity.
    Toth K; Kovacs M; Zarandi M; Halmos G; Groot K; Nagy A; Kele Z; Schally AV
    J Pept Res; 1998 Feb; 51(2):134-41. PubMed ID: 9516049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
    Korbonits M; Little JA; Forsling ML; Tringali G; Costa A; Navarra P; Trainer PJ; Grossman AB
    J Neuroendocrinol; 1999 Jul; 11(7):521-8. PubMed ID: 10444309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Naturally-occurring missense mutations in the human growth hormone-releasing hormone receptor alter ligand binding.
    Alba M; Salvatori R
    J Endocrinol; 2005 Sep; 186(3):515-21. PubMed ID: 16135671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.
    Granato G; Gesmundo I; Pedrolli F; Kasarla R; Begani L; Banfi D; Bruno S; Lopatina T; Brizzi MF; Cai R; Sha W; Ghigo E; Schally AV; Granata R
    Front Immunol; 2023; 14():1231363. PubMed ID: 37649486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A method for evaluation of activity of antagonistic analogs of growth hormone-releasing hormone in a superfusion system.
    Rekasi Z; Schally AV
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2146-9. PubMed ID: 8460121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.
    Cai R; Schally AV; Cui T; Szalontay L; Halmos G; Sha W; Kovacs M; Jaszberenyi M; He J; Rick FG; Popovics P; Kanashiro-Takeuchi R; Hare JM; Block NL; Zarandi M
    Peptides; 2014 Feb; 52():104-12. PubMed ID: 24373935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth hormone-releasing peptides: clinical and basic aspects.
    Argente J; García-Segura LM; Pozo J; Chowen JA
    Horm Res; 1996; 46(4-5):155-9. PubMed ID: 8950613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer.
    Papadia A; Schally AV; Halmos G; Varga JL; Seitz S; Buchholz S; Rick F; Zarandi M; Bellyei S; Treszl A; Szalontay L; Lucci JA
    Horm Metab Res; 2011 Oct; 43(11):816-20. PubMed ID: 22009378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of single-stranded DNA aptamers for specific Bisphenol a detection.
    Jo M; Ahn JY; Lee J; Lee S; Hong SW; Yoo JW; Kang J; Dua P; Lee DK; Hong S; Kim S
    Oligonucleotides; 2011; 21(2):85-91. PubMed ID: 21413891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.
    Rick FG; Schally AV; Szalontay L; Block NL; Szepeshazi K; Nadji M; Zarandi M; Hohla F; Buchholz S; Seitz S
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1655-60. PubMed ID: 22307626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus.
    Villas-Boas Weffort RF; Ramos-Dias JC; Chipoch C; Lengyel AM
    Metabolism; 1997 Jun; 46(6):706-10. PubMed ID: 9186309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone.
    Neyzi O; Yordam N; Ocal G; Bundak R; Darendeliler F; Açikgöz E; Berberoğlu M; Günöz H; Saka N; Calikoğlu AS
    Acta Paediatr Suppl; 1993 Mar; 388():16-21; discussion 22. PubMed ID: 8329826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
    Rigamonti AE; Cavallera G; Bonomo S; Deghenghi R; Locatelli V; Cella SG; Müller EE
    Eur J Endocrinol; 2001 Nov; 145(5):635-44. PubMed ID: 11720883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.
    Popovics P; Schally AV; Salgueiro L; Kovacs K; Rick FG
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1359-1364. PubMed ID: 28123062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of long-term dietary interventions on pituitary growth hormone-releasing hormone receptor in aging rats and potential mechanisms of action.
    Bédard K; Robinette K; Ferland G; Gaudreau P
    Mech Ageing Dev; 2010 Mar; 131(3):169-78. PubMed ID: 20122951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.